» Articles » PMID: 28704563

Self-propagating, Protease-resistant, Recombinant Prion Protein Conformers with or Without in Vivo Pathogenicity

Abstract

Prions, characterized by self-propagating protease-resistant prion protein (PrP) conformations, are agents causing prion disease. Recent studies generated several such self-propagating protease-resistant recombinant PrP (rPrP-res) conformers. While some cause prion disease, others fail to induce any pathology. Here we showed that although distinctly different, the pathogenic and non-pathogenic rPrP-res conformers were similarly recognized by a group of conformational antibodies against prions and shared a similar guanidine hydrochloride denaturation profile, suggesting a similar overall architecture. Interestingly, two independently generated non-pathogenic rPrP-res were almost identical, indicating that the particular rPrP-res resulted from cofactor-guided PrP misfolding, rather than stochastic PrP aggregation. Consistent with the notion that cofactors influence rPrP-res conformation, the propagation of all rPrP-res formed with phosphatidylglycerol/RNA was cofactor-dependent, which is different from rPrP-res generated with a single cofactor, phosphatidylethanolamine. Unexpectedly, despite the dramatic difference in disease-causing capability, RT-QuIC assays detected large increases in seeding activity in both pathogenic and non-pathogenic rPrP-res inoculated mice, indicating that the non-pathogenic rPrP-res is not completely inert in vivo. Together, our study supported a role of cofactors in guiding PrP misfolding, indicated that relatively small structural features determine rPrP-res' pathogenicity, and revealed that the in vivo seeding ability of rPrP-res does not necessarily result in pathogenicity.

Citing Articles

Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions.

Perez-Castro M, Perez-Castro M, Erana H, Vidal E, Charco J, Lorenzo N PLoS Pathog. 2025; 21(1):e1012890.

PMID: 39841704 PMC: 11774496. DOI: 10.1371/journal.ppat.1012890.


Study of Insulin Aggregation and Fibril Structure under Different Environmental Conditions.

Ziaunys M, Mikalauskaite K, Sakalauskas A, Smirnovas V Int J Mol Sci. 2024; 25(17).

PMID: 39273350 PMC: 11395423. DOI: 10.3390/ijms25179406.


Essential Components of Synthetic Infectious Prion Formation De Novo.

Jack K, Jackson G, Bieschke J Biomolecules. 2022; 12(11).

PMID: 36421708 PMC: 9687555. DOI: 10.3390/biom12111694.


Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.

Ma J, Zhang J, Yan R Viruses. 2022; 14(9).

PMID: 36146746 PMC: 9504972. DOI: 10.3390/v14091940.


Prion strains: shining new light on old concepts.

Block A, Bartz J Cell Tissue Res. 2022; 392(1):113-133.

PMID: 35796874 PMC: 11318079. DOI: 10.1007/s00441-022-03665-2.


References
1.
Morales R, Duran-Aniotz C, Diaz-Espinoza R, Camacho M, Soto C . Protein misfolding cyclic amplification of infectious prions. Nat Protoc. 2012; 7(7):1397-409. PMC: 4049227. DOI: 10.1038/nprot.2012.067. View

2.
Wang F, Wang X, Yuan C, Ma J . Generating a prion with bacterially expressed recombinant prion protein. Science. 2010; 327(5969):1132-5. PMC: 2893558. DOI: 10.1126/science.1183748. View

3.
Wang F, Zhang Z, Wang X, Li J, Zha L, Yuan C . Genetic informational RNA is not required for recombinant prion infectivity. J Virol. 2011; 86(3):1874-6. PMC: 3264365. DOI: 10.1128/JVI.06216-11. View

4.
P B Gomes M, Millen T, Ferreira P, Cunha E Silva N, Vieira T, Almeida M . Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells. J Biol Chem. 2008; 283(28):19616-25. PMC: 2443653. DOI: 10.1074/jbc.M802102200. View

5.
Timmes A, Moore R, Fischer E, Priola S . Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS One. 2013; 8(7):e71081. PMC: 3728029. DOI: 10.1371/journal.pone.0071081. View